UK-based drugmaker GlaxoSmithKline (GSK) will reinstate its contract pharmacy restrictions in Kansas next month, making it the fourth drug manufacturer [...] …
Articles by : Bella Czajkowski, National Correspondent
After the Health Resources and Services Administration (HRSA) canceled its annual 340B grantee recertification webinar amid disruptions from a federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Conservative groups and advocates have recently ramped up efforts to combat the growing number of state 340B contract pharmacy access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A California-based 340B hospital that sued the federal government for denying its 340B access has dropped the lawsuit after being [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A recent study suggested that 340B providers prescribe more drugs for treating breast cancer, but do not have any significant [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Ireland-based Alkermes announced this week that it will become the third drugmaker to reinstate contract pharmacy restrictions in Kansas and [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
340B covered entities this week reported continued disruptions in Office of Pharmacy Affairs (OPA) operations, as well as uncertainty around [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A France-based drugmaker recently reinstated its contract pharmacy restrictions in Kansas following a successful challenge of the state’s contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A newly introduced Connecticut bill would require 340B covered entities to report how they use program savings as a condition [...] …